Rilzabrutinib, a potent and selective Bruton’s tyrosine kinase inhibitor, suppresses reactive oxygen species production and CD11b activation in human eosinophils
Year: 2024
Type: conference-abstract
Authors: Kai-Ting Shade, Shin Mukai, Alexandra Hicks
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404104372